E-LIB Suche - Ergebnisse für: Johnson, Syd - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Tailoring CD19xCD3-DART exposure enhances T-cells to eradic..:

Circosta, Paola ; Elia, Angela Rita ; Landra, Indira...
OncoImmunology. 7 (2018) 4 - p. , 2018

Link: https://doi.org/10.1080/..

2

Defining New Therapeutics Using a More Immunocompetent Mous..:

Pinto, Amelia K. ; Brien, James D. ; Lam, Chia-Ying Kao...
mBio. 6 (2015) 5 - p. , 2015

Link: https://doi.org/10.1128/..

3

Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Aff..:

Sloan, Derek D. ; Lam, Chia-Ying Kao ; Irrinki, Alivelu...
PLOS Pathogens. 11 (2015) 11 - p. e1005233 , 2015

Link: https://doi.org/10.1371/..

4

Potent Dengue Virus Neutralization by a Therapeutic Antibod..:

Edeling, Melissa A. ; Austin, S. Kyle ; Shrestha, Bimmi...
PLoS Pathogens. 10 (2014) 4 - p. e1004072 , 2014

Link: https://doi.org/10.1371/..

5

Correction: Therapeutic Efficacy of Antibodies Lacking FcγR..:

Williams, Katherine L. ; Sukupolvi-Petty, Soila ; Beltramello, Martina...
PLoS Pathogens. 9 (2013) 3 - p. , 2013

Link: https://doi.org/10.1371/..

6

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabe..:

Hagopian, William ; Ferry Jr., Robert J. ; Sherry, Nicole...
Diabetes. 62 (2013) 11 - p. 3901-3908 , 2013

Link: https://doi.org/10.2337/..

7

Novel Applications of Bispecific DART® Proteins:

, In: Fusion Protein Technologies for Biopharmaceuticals,

Johnson, Syd ; Barat, Bhaswati ; Li, Hua W.... - p. 545-555 , 2013

Link: https://doi.org/10.1002/..

8

Development of a Highly Protective Combination Monoclonal A..:

Pal, Pankaj ; Dowd, Kimberly A. ; Brien, James D....
PLoS Pathogens. 9 (2013) 4 - p. e1003312 , 2013

Link: https://doi.org/10.1371/..

9

Therapeutic Efficacy of Antibodies Lacking FcγR against Let..:

Williams, Katherine L. ; Sukupolvi-Petty, Soila ; Beltramello, Martina...
PLoS Pathogens. 9 (2013) 2 - p. e1003157 , 2013

Link: https://doi.org/10.1371/..

10

Structural Basis of Differential Neutralization of DENV-1 G..:

Austin, S. Kyle ; Dowd, Kimberly A. ; Shrestha, Bimmi...
PLoS Pathogens. 8 (2012) 10 - p. e1002930 , 2012

Link: https://doi.org/10.1371/..

11

Teplizumab for treatment of type 1 diabetes (Protégé study)..:

Sherry, Nicole ; Hagopian, William ; Ludvigsson, Johnny...
The Lancet. 378 (2011) 9790 - p. 487-497 , 2011

Link: https://doi.org/10.1016/..

12

Anti-tumor activity and toxicokinetics analysis of MGAH22, ..:

Nordstrom, Jeffrey L ; Gorlatov, Sergey ; Zhang, Wenjun...
Breast Cancer Research. 13 (2011) 6 - p. , 2011

Link: https://doi.org/10.1186/..

13

Nonclinical Evaluation of GMA161—An Antihuman CD16 (FcγRIII..:

Flaherty, Meghan M. ; MacLachlan, Timothy K. ; Troutt, Misty...
Toxicological Sciences. 125 (2011) 1 - p. 299-309 , 2011

Link: https://doi.org/10.1093/..

14

Lethal Antibody Enhancement of Dengue Disease in Mice Is Pr..:

Balsitis, Scott J. ; Williams, Katherine L. ; Lachica, Ruben...
PLoS Pathogens. 6 (2010) 2 - p. e1000790 , 2010

Link: https://doi.org/10.1371/..

15

Monoclonal antibody produced in plants efficiently treats W..:

Lai, Huafang ; Engle, Michael ; Fuchs, Anja...
Proceedings of the National Academy of Sciences. 107 (2010) 6 - p. 2419-2424 , 2010

Link: https://doi.org/10.1073/..

1-15